Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,787
Closed -$245K 522
2026
Q1
$245K Sell
10,787
-953
-8% -$22.5K 0.02% 448
2025
Q4
$313K Buy
11,740
+320
+3% +$9.46K 0.02% 358
2025
Q3
$346K Buy
11,420
+2,863
+33% +$86.8K 0.03% 328
2025
Q2
$268K Sell
8,557
-5,181
-38% -$171K 0.03% 319
2025
Q1
$525K Sell
13,738
-1,165
-8% -$49.4K 0.05% 208
2024
Q4
$654K Sell
14,903
-1,083
-7% -$47.6K 0.05% 237
2024
Q3
$688K Buy
15,986
+2,635
+20% +$117K 0.05% 225
2024
Q2
$603K Buy
13,351
+1,210
+10% +$62.8K 0.05% 236
2024
Q1
$758K Buy
12,141
+5,218
+75% +$312K 0.06% 205
2023
Q4
$388K Buy
+6,923
New +$345K 0.03% 331

Other funds holding ENOV

Trust Point Inc's ENOV Position: Q2 2026 in Review

Trust Point Inc sold out of Enovis (ENOV) in Q2 2026, closing a stake of 10,787 shares — an estimated $245K sold.

Trust Point Inc first reported a position in ENOV in Q4 2023 and held it in 10 quarters. The position peaked at $758K in Q1 2024. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Trust Point Inc reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
  • Trust Point Inc sold 10,787 Enovis shares in Q2 2026, an estimated $245K.
  • Trust Point Inc first reported a position in Enovis in Q4 2023 and held it in 10 quarters.
  • Trust Point Inc's Enovis position peaked at $758K in Q1 2024.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.